Spoken Alpha
QDEL
QuidelOrtho Corp
Overview
QuidelOrtho provides diagnostic testing solutions for clinical laboratories, point-of-care settings, and blood banks across more than 140 countries.
QuidelOrtho Corp is a Healthcare company operating in Medical Devices with a $739.9M market cap.
Most recent reported earnings: Q3 FY2026 (Nov 3, 2026).
21 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from SEC 10-K filing, 2026-08-30.
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
- Q1 FY2026Earnings2026-05-059 Q&A exchanges
- Q4 FY2025Earnings2026-02-1117 Q&A exchanges
- Q3 FY2025Earnings2025-11-0613 Q&A exchanges
- Q2 FY2025Earnings2025-08-0618 Q&A exchanges
- Q1 FY2025Earnings2025-05-0716 Q&A exchanges
- Q4 FY2024Earnings2025-02-1221 Q&A exchanges
- Q3 FY2024Earnings2024-11-0724 Q&A exchanges
- Q2 FY2024Earnings2024-07-316 Q&A exchanges
- Q1 FY2024Earnings2024-05-0816 Q&A exchanges
- Q4 FY2023Earnings2024-02-1330 Q&A exchanges
- Q3 FY2023Earnings2023-11-0126 Q&A exchanges
- Q2 FY2023Earnings2023-08-0816 Q&A exchanges
- Q1 FY2023Earnings2023-05-0317 Q&A exchanges
- Q4 FY2022Earnings2023-02-1534 Q&A exchanges
- Q3 FY2022Earnings2022-11-029 Q&A exchanges
- Q2 FY2022Earnings2022-08-0415 Q&A exchanges
- Q1 FY2022Earnings2022-05-0421 Q&A exchanges
- Q4 FY2021Earnings2022-02-1726 Q&A exchanges
- Q3 FY2021Earnings2021-11-0418 Q&A exchanges
- Q2 FY2021Earnings2021-08-0519 Q&A exchanges
- Q1 FY2021Earnings2021-05-0636 Q&A exchanges
History
Earnings history
- Q3 FY20262026-11-03EPS— vs $0.18—Rev— vs ——EODHD
- Q2 FY20262026-08-05EPS$0.13 vs $-0.04+100.0%Rev$630.9M vs ——EODHD
- Q1 FY20262026-05-04EPS$-0.04 vs $0.36-100.0%Rev$619.8M vs ——EODHD
- Q4 FY20252026-02-10EPS$0.46 vs $0.42+9.5%Rev$723.6M vs ——EODHD
- Q3 FY20252025-11-04EPS$0.80 vs $0.51+56.9%Rev$699.9M vs ——EODHD
- Q2 FY20252025-08-04EPS$0.12 vs $0.01+100.0%Rev$613.9M vs ——EODHD
- Q1 FY20252025-05-06EPS$0.74 vs $0.59+25.4%Rev$692.8M vs ——EODHD
- Q4 FY20242025-02-11EPS$0.63 vs $0.58+8.6%Rev$707.8M vs ——EODHD
- Q3 FY20242024-11-06EPS$0.85 vs $0.32+100.0%Rev$727.1M vs ——EODHD
- Q2 FY20242024-07-30EPS$-0.07 vs $-0.24+70.8%Rev$637.0M vs ——EODHD
- Q1 FY20242024-05-07EPS$0.44 vs $0.40+10.0%Rev$711.0M vs ——EODHD
- Q4 FY20232024-02-12EPS$1.17 vs $2.06-43.2%Rev$742.6M vs ——EODHD
- Q3 FY20232023-10-31EPS$0.90 vs $0.56+60.7%Rev$744.0M vs ——EODHD
- Q2 FY20232023-08-07EPS$0.26 vs $0.260.0%Rev$665.1M vs ——EODHD
- Q1 FY20232023-05-02EPS$1.80 vs $1.43+25.9%Rev$846.1M vs ——EODHD
- Q4 FY20222023-02-14EPS$1.76 vs $1.42+23.9%Rev$866.5M vs ——EODHD
- Q3 FY20222022-11-01EPS$1.85 vs $0.69+100.0%Rev$783.8M vs ——EODHD
- Q2 FY20222022-08-03EPS$2.34 vs $2.68-12.7%Rev$613.4M vs ——EODHD
- Q1 FY20222022-05-03EPS$11.66 vs $9.43+23.6%Rev$1.00B vs ——EODHD
- Q4 FY20212022-02-16EPS$7.29 vs $5.61+29.9%Rev$636.9M vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-11-03 | — | $0.18 | — | — | — | — | EODHD |
| Q2 FY2026 | 2026-08-05 | $0.13 | $-0.04 | +100.0% | $630.9M | — | — | EODHD |
| Q1 FY2026 | 2026-05-04 | $-0.04 | $0.36 | -100.0% | $619.8M | — | — | EODHD |
| Q4 FY2025 | 2026-02-10 | $0.46 | $0.42 | +9.5% | $723.6M | — | — | EODHD |
| Q3 FY2025 | 2025-11-04 | $0.80 | $0.51 | +56.9% | $699.9M | — | — | EODHD |
| Q2 FY2025 | 2025-08-04 | $0.12 | $0.01 | +100.0% | $613.9M | — | — | EODHD |
| Q1 FY2025 | 2025-05-06 | $0.74 | $0.59 | +25.4% | $692.8M | — | — | EODHD |
| Q4 FY2024 | 2025-02-11 | $0.63 | $0.58 | +8.6% | $707.8M | — | — | EODHD |
| Q3 FY2024 | 2024-11-06 | $0.85 | $0.32 | +100.0% | $727.1M | — | — | EODHD |
| Q2 FY2024 | 2024-07-30 | $-0.07 | $-0.24 | +70.8% | $637.0M | — | — | EODHD |
| Q1 FY2024 | 2024-05-07 | $0.44 | $0.40 | +10.0% | $711.0M | — | — | EODHD |
| Q4 FY2023 | 2024-02-12 | $1.17 | $2.06 | -43.2% | $742.6M | — | — | EODHD |
| Q3 FY2023 | 2023-10-31 | $0.90 | $0.56 | +60.7% | $744.0M | — | — | EODHD |
| Q2 FY2023 | 2023-08-07 | $0.26 | $0.26 | 0.0% | $665.1M | — | — | EODHD |
| Q1 FY2023 | 2023-05-02 | $1.80 | $1.43 | +25.9% | $846.1M | — | — | EODHD |
| Q4 FY2022 | 2023-02-14 | $1.76 | $1.42 | +23.9% | $866.5M | — | — | EODHD |
| Q3 FY2022 | 2022-11-01 | $1.85 | $0.69 | +100.0% | $783.8M | — | — | EODHD |
| Q2 FY2022 | 2022-08-03 | $2.34 | $2.68 | -12.7% | $613.4M | — | — | EODHD |
| Q1 FY2022 | 2022-05-03 | $11.66 | $9.43 | +23.6% | $1.00B | — | — | EODHD |
| Q4 FY2021 | 2022-02-16 | $7.29 | $5.61 | +29.9% | $636.9M | — | — | EODHD |
Source: EODHD. QDEL reported actuals as published; sparse fields render as —.
Top executives
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
- Brian J BlaserCEO2 yr 4 mo9 callsCurrent
- Joseph M BuskyCFO4 yr 4 mo17 callsCurrent
- Nathaniel SisitskyChief Legal Officer6 mono recorded callsCurrent
- Philip D McLellanChief Operations Officer1 yr 10 mono recorded callsCurrent
- Michelle A HodgesChief Legal Officer1 yr 10 mono recorded callsCurrent
- Jonathan Philip SiegristEVP of R&D & CTO1 yr 11 mono recorded callsCurrent
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for QDEL.
$ curl https://api.spokenalpha.com/v1/companies/QDELFAQ
Frequently asked about QDEL
Where can I find QuidelOrtho Corp's (QDEL) earnings call transcripts?
Spoken Alpha indexes QDEL's earnings call transcripts at https://spokenalpha.com/companies/QDEL. Each call links to attributed speakers and parsed analyst Q&A. QuidelOrtho Corp's own investor relations page is at https://ir.quidelortho.com/home/default.aspx.
When was QuidelOrtho Corp's most recent earnings call?
QuidelOrtho Corp (QDEL) held its most recent earnings call on 2026-05-05, covering fiscal Q1 2026.
What sector is QDEL in?
QuidelOrtho Corp (QDEL) operates in the Healthcare sector (Medical Devices industry).